Results 261 to 270 of about 2,802,074 (283)

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Cancer Cell, 2022
Yun Fan, Guanghai Dai, Junhe Li
exaly  

Features of “ET plus” correlate with age and tremor duration: “ET plus” may be a disease stage rather than a subtype of essential tremor

Parkinsonism and Related Disorders, 2021
Stephanie Cosentino, Edward Huey
exaly  

An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma

Cancer Cell, 2023
Rui-Hua Xu, Yan-Xing Chen
exaly  

Ocena kliniczna uszczelniacza AH Plus

Magazyn Stomatologiczny, 1998
Luciński, Rafał, Szczepankiewicz, Włodzimierz   +1 more
openaire  

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of Oncology, 2011
M Hiura, Toshiko Jobo, N Yaegashi
exaly  

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, S Nakamori, N Okano
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
Mitchell Shiffman, Michael Peter Manns, Zachary Goodman   +2 more
exaly  

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus

Journal of Infection, 2016
Daniela Maria Cirillo, Ilaria Pepponi, Fabrizio Palmieri   +2 more
exaly  

Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection

Journal of Infection, 2020
Luigi Codecasa, Fabrizio Palmieri, Delia Goletti   +2 more
exaly  

Challenges and Opportunities of Modeling Biomass Gasification in Aspen Plus: A  Review

Chemical Engineering and Technology, 2020
Thomas Zeng, Özge Çepelioğullar Mutlu   +1 more
exaly